Michael E. Larner

Michael E. Larner

Partner
Northern Virginia

Email [email protected]​hoganlovells.com

Phone +1 703 610 6100

Fax +1 703 610 6200

Practice groupIntellectual Property, Media, and Technology

"Thoughtful and meticulous"

Legal 500 US: Media, Technology, and Telecoms, 2018

With over 20 years of experience, Michael Larner effectively counsels clients on their most important commercial and intellectual property transactions.

Michael's experience spans a wide range of industries, including information technology, life sciences, and education. He regularly works with clients on innovative technologies, including technology licensing and development agreements, cloud computing transactions, outsourcing relationships, collaborations, and content licensing.  

Michael understands the technology sector and provides practical advice to meet his client's business objectives. He is a respected leader on open-source software issues, evaluating open-source licensing strategies, assessing the risks of using and developing open-source software, and drafting policies to manage this risk. He also frequently counsels clients on issues associated with their online and mobile presence, as well as advising on transactional, data security, social media, and intellectual property issues.

In the life sciences industry, he helps companies successfully commercialize their products, with a focus on new product launches and digital health. Pharmaceutical and biotechnology manufacturers turn to Michael to establish their distribution channel, where he advises on agreements with third party logistics providers, specialty pharmacies and specialty distributors. He also helps establish complex outsourced services relationships needed for a successful product launch. His experience with both startup and established manufacturers provides a foundation for efficient and insightful advice.

In the education sector, Michael assists universities, testing providers, and other education clients with distance learning initiatives, business process outsourcing and structuring, and negotiating complex software licensing and services deals.

Awards and recognitions

2016-2019

Media, Technology, and Telecoms: Outsourcing
Legal 500 US

2014-2016

Legal Elite, Intellectual Property
Virginia Business magazine

2013

Media, Technology, and Telecoms: Technology: Transactions
Legal 500 US

2008

Legal Elite, Young Lawyers
Virginia Business magazine

Education and admissions

Education

J.D., University of Pennsylvania Law School, cum laude, 1999

A.B., Lafayette College, summa cum laude, Phi Beta Kappa, 1996

Memberships

Member, International Technology Law Association

Member, National Association of College and University Attorneys

Member, Science and Technology Law Section, American Bar Association

Bar admissions and qualifications

Virginia

Pennsylvania

New Jersey

Representative experience

Lead counsel for education testing company, negotiating deal to outsource over US$1bn in test development, test delivery, and related services.

Representing a Washington, D.C., museum on all aspects of IP and content licensing, artifact acquisitions, and sponsorship opportunities.

Advising pharmaceutical manufacturers on commercial relationships for successful product launch, including specialty pharmacy and distribution, hub services, and other outsourced services agreements.

Represent higher education institutions with transactions to outsource bundled services and technologies for the launch of online academic programs.

Developing cloud platform agreement for online organ transplant management solution.

Representing a major U.S. university on copyright ownership and Creative Commons license issues.

Advising university on software development, licensing and cloud computing deals to create a next generation online learning management system.

Counseled major U.S. healthcare client on open source issues related to the acquisition of a business intelligence and analytics software company.

Drafting and negotiating contract manufacturing agreements for development and manufacturing of clinical stage product.

Assisting multiple gene therapy companies with establishing novel specialty pharmacy distribution relationships for the distribution of gene therapy products to qualified treatment centers.

Latest thinking and events

Hogan Lovells Publications

Buyer and Seller Beware: Impact of open source software in corporate acquisitions IP Alert

Loading data